Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Top 100 Creative Companies

Small diseases need big picture communications

An early commitment to communications planning in rare diseases is worth the risk

- PMLiVE

Tablet detailing

As customer expectations increase, so must pharma's approach

Novartis building

CHMP backs Xolair for severe hives

Novartis set to expand indications for asthma drug

J&J expected to make best use of digital in 2014

Company's strong approach to marketing strategy praised in Digital Futures 2014 survey

- PMLiVE

NICE set to extend MabThera recommendation

Says Roche’s drug can be used on NHS to treat two serious forms of vasculitis

- PMLiVE

Amgen cholesterol antibody scores in another phase III trial

Evolocumab effective in patients who cannot take statins

- PMLiVE

Shire elects new chair

Susan Kilsby to replace Matthew Emmens who retires

- PMLiVE

Biocon and Advaxis partner on cancer immunotherapy

Will develop ADXS-HPV for cervical cancer

Orphan indication? No easy access

Health technology assessment for orphan drugs continues to present challenges for pharmaceutical companies

- PMLiVE

Infographic: Orphan drug market

A visual guide to the orphan drug and rare disease market for pharma

Novartis building

New York plant set to close as Novartis continues cutbacks

More than 500 employees face the axe

- PMLiVE

Pharma slammed for undermining South African IP reforms

Government criticises leaked strategy to block plans to change patent protection laws

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links